[1] PANTONI L. Cerebral small vessel disease：from

pathogenesis and clinical characteristics to

therapeutic challenges[J]. Lancet Neurol，2010，9

（7）：689-701.

[2] SCHMIDT R，SEILER S，LOITFELDER M.

Longitudinal change of small-vessel disease-related

brain abnormalities[J]. J Cereb Blood Flow Metab，

2016，36（1）：26-39.

[3] CANNISTRARO R J，BADI M，EIDELMAN B H，

et al. CNS small vessel disease：a clinical review[J].

Neurology，2019，92（24）：1146-1156.

[4] GREGOIRE S M，CHAUDHARY U J，BROWNM M，et al. The Microbleed Anatomical Rating

Scale（MARS）：reliability of a tool to map brain

microbleeds[J]. Neurology，2009，73（21）：1759-

1766.

[5] MARTINEZ-RAMIREZ S，GREENBERG S M，

VISWANATHAN A. Microbleeds do not affect

rate of cognitive decline in Alzheimer disease[J].

Neurology，2013，80（13）：1266.

[6] 顾雨铖，刘任远，秦若梦，等. 总MRI脑小血管病评

分与认知功能的相关性[J]. 国际脑血管病杂志，2018，

（7）：521-527.

[7] LAU K K，LI L，SCHULZ U，et al. Total small

vessel disease score and risk of recurrent stroke：

validation in 2 large cohorts[J]. Neurology，2017，88

（24）：2260-2267.

[8] UITERWIJK R，VAN OOSTENBRUGGE R J，

HUIJTS M，et al. Total cerebral small vessel disease

MRI score is associated with cognitive decline in

executive function in patients with hypertension[J].

Front Aging Neurosci，2016，8：301.

[9] LOOS C M，MCHUTCHISON C，CVORO V，et

al. The relation between total cerebral small vessel

disease burden and gait impairment in patients with

minor stroke[J]. Int J Stroke，2018，13（5）：518-524.

[10] LIOUTAS V A，WU B，NORTON C，et al.

Cerebral small vessel disease burden and functional

and radiographic outcomes in intracerebral

hemorrhage[J]. J Neurol，2018，265（12）：2803-

2814.

[11] FIRBANK M J，WISEMAN R M，BURTON E J，et

al. Brain atrophy and white matter hyperintensity

change in older adults and relationship to blood

pressure. Brain atrophy，WMH change and blood

pressure[J]. J Neurol，2007，254（6）：713-721.

[12] BOUASQUEVISQUE D S，BENAVENTE O R，

SHOAMANESH A. Antiplatelet therapy in cerebral

small vessel disease[J]. Curr Neurol Neurosci Rep，

2019，19（9）：61.